Is a hospital-based addiction consultation service cost-effective for increasing the initiation of US FDA-approved medication for opioid use disorder in the hospital and linking patients to follow-up care after discharge? Yes, concluded Rand et al after an incremental cost-effectiveness analysis based on the Start trial, at 3 major academic medical centers.


